IL21 and arthritic joint disease: With this study we demonstrated that full inhibition of both IL-6 and IL-21 effectively abrogates Th17 differentiation, and that, despite the minor effect on Th17 development, a combination therapy neutralizing both cytokine pathways is more effective in treating early T cell-driven experimental arthritis than targeting either cytokine.